WallStreetZenWallStreetZen

NYSE: BMY
Bristol Myers Squibb Co Stock

Overview
ForecastEarningsDividendOwnership
$50.23+0.25 (+0.5%)
Updated Dec 5, 2023
BMY Price
$50.23
Fair Value Price
N/A
Market Cap
$102.21B
52 Week Low
$48.25
52 Week High
$80.67
P/E
12.65x
P/B
3.52x
P/S
2.7x
PEG
0.44x
Dividend Yield
4.54%
Revenue
$44.94B
Earnings
$8.29B
Gross Margin
76.5%
Operating Margin
19.15%
Profit Margin
18.4%
Debt to Equity
2.15
Operating Cash Flow
$13B
Beta
0.52
Next Earnings
Feb 2, 2024
Ex-Dividend
N/A
Next Dividend
N/A

BMY Overview

Bristol-Myers Squibb Company is one of the world's largest pharmaceutical companies. It manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders. Unlike some of its more diversified peers, Bristol-Myers has exited several nonpharmaceutical businesses to focus on branded specialty drugs. The company was founded in 1887 and is headquartered in New York, NY.

Zen Score

–
Industry Average (44)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BMY scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BMY ($50.23) is trading below its intrinsic value of $58.67, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BMY is good value based on its earnings relative to its share price (12.65x), compared to the US market average (30.4x)
P/E vs Market Valuation
BMY is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more BMY due diligence checks available for Premium users.

Be the first to know about important BMY news, forecast changes, insider trades & much more!

BMY News

Valuation

BMY price to earnings (PE)

For valuing profitable companies with steady earnings
Company
12.65x
Industry
43.29x
Market
30.4x
BMY is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BMY is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

BMY price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.52x
Industry
5.36x
BMY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BMY price to earnings growth (PEG)

For valuing profitable companies with growth potential
BMY is good value based... subscribe to Premium to read more.
PEG Value Valuation

BMY's financial health

Profit margin

Revenue
$11.0B
Net Income
$1.9B
Profit Margin
17.6%
BMY's Earnings (EBIT) of $8.61B... subscribe to Premium to read more.
Interest Coverage Financials
BMY's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$91.3B
Liabilities
$62.2B
Debt to equity
2.15
BMY's short-term assets ($27.63B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BMY's long-term liabilities ($38.74B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BMY's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
BMY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$4.8B
Investing
-$410.0M
Financing
-$5.2B
BMY's operating cash flow ($12.91B)... subscribe to Premium to read more.
Debt Coverage Financials

BMY vs General Drug Manufacturer Stocks

TickerMarket Cap1d %P/EP/B
BMY$102.21B+0.50%12.65x3.52x
GILD$98.46B+0.87%16.78x4.41x
SNY$115.84B-1.45%11.99x1.42x
GSK$73.66B-0.82%9.17x4.60x
AMGN$144.96B-0.61%19.14x18.93x
View Top General Drug Manufacturer Stocks

Bristol Myers Squibb Co Stock FAQ

What is Bristol Myers Squibb Co's quote symbol?

(NYSE: BMY) Bristol Myers Squibb Co trades on the NYSE under the ticker symbol BMY. Bristol Myers Squibb Co stock quotes can also be displayed as NYSE: BMY.

If you're new to stock investing, here's how to buy Bristol Myers Squibb Co stock.

What is the 52 week high and low for Bristol Myers Squibb Co (NYSE: BMY)?

(NYSE: BMY) Bristol Myers Squibb Co's 52-week high was $80.67, and its 52-week low was $48.25. It is currently -37.73% from its 52-week high and 4.1% from its 52-week low.

How much is Bristol Myers Squibb Co stock worth today?

(NYSE: BMY) Bristol Myers Squibb Co currently has 2,034,757,742 outstanding shares. With Bristol Myers Squibb Co stock trading at $50.23 per share, the total value of Bristol Myers Squibb Co stock (market capitalization) is $102.21B.

Bristol Myers Squibb Co stock was originally listed at a price of $47.32 in Dec 31, 1997. If you had invested in Bristol Myers Squibb Co stock at $47.32, your return over the last 25 years would have been 6.16%, for an annualized return of 0.24% (not including any dividends or dividend reinvestments).

How much is Bristol Myers Squibb Co's stock price per share?

(NYSE: BMY) Bristol Myers Squibb Co stock price per share is $50.23 today (as of Dec 5, 2023).

What is Bristol Myers Squibb Co's Market Cap?

(NYSE: BMY) Bristol Myers Squibb Co's market cap is $102.21B, as of Dec 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Bristol Myers Squibb Co's market cap is calculated by multiplying BMY's current stock price of $50.23 by BMY's total outstanding shares of 2,034,757,742.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.